Delivery Order SPE2DB20D1100-SPE2DB25FE6M0
Award Date 9/12/25
Potential Completion Date 10/3/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,119.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets (5 units) on August 21, 2025. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. INQOVI is an FDA-approved combination chemotherapy medication used in cancer treatment, reflecting the agency's critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,119.36 to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets on August 29, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside contract utilizing firm fixed pricing was issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide INQOVI 35 MG-100 MG tablets. The $4,830.47 contract has a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for INQOVI 35 mg-100 mg tablets, a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, valued at $5,119.36, represents a competitive award with no set-aside designation and carries an ultimate completion date of August 22, 2025. The contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,119.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for INQOVI 35 mg-100 mg tablets (5-count units), with performance expected in Conshohocken, Pennsylvania by September 10, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves...
- This is a $5,119.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide INQOVI 35 MG-100 MG tablets. The contract has an ultimate completion date of June 20, 2025 and is not set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for supplying a wide...
- The Defense Logistics Agency awarded a $5,119.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets (5 units) on August 22, 2025, with completion targeted for September 15, 2025. This non-set-aside award represents a child order under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564134395! INQOVI 35 MG-100 MG TABLET UU 5S. The award, valued at $4,830.47, has an ultimate completion date of April 22, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, specializes in supplying pharmaceuticals, medical supplies, and related distribution services to...
- This delivery order, issued by the Defense Logistics Agency (DLA) on July 23, 2025, awards AmerisourceBergen Drug Corp $5,119.36 for the supply of INQOVI 35 mg-100 mg tablets in quantities of 5 units. The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with a completion date of August 13, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,740.79 firm fixed-price delivery order is for the supply of INQOVI 35 MG-100 MG tablets, with a period of performance ending on March 27, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...